Virbac SA (VRBCF PINK) stock market data APIs
$345.5742
0(0%)
as of September 16, 2025
Try our APIs with
free plan!
Virbac SA Financial Data Overview
Price chart is built with
Anychart
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Prev. Close
345.5742
Open
345.5742
High
345.5742
Low
345.5742
52 wk Range
320.9629-380.8165
Market Cap
3 294 M
P/E Ratio
17.0359
Shares Outstanding
8 378 K
Revenue
1 433 M
Dividends (Yield)
0.0042
Beta
0.819
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Virbac SA data using free add-ons & libraries
Get Virbac SA Fundamental Data
Virbac SA Fundamental data includes:
- Net Revenue: 1 433 M
- EBITDA: 262 M
- Earnings Per Share: 20
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-09-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Virbac SA News
New
Virbac: 2025 Half-year results
Virbac Solid revenue growth in the first half of 2025 of +5.6% at constant exchange rates and scope Adjusted recurring operating income² of 18.3% as a ratio to revenue, in line with our expectation...
GL Events Valuation in Focus After Strong 61.7% Year-to-Date Rally
Thinking about what to do with your GL Events shares? Whether you are sizing up an entry point or reassessing your position after a strong rally, now is a great time to take stock of what is really ha...
Evaluating Virbac’s Future After Recent 9.3% Decline and Market Volatility in 2025
If you are eyeing Virbac and weighing your next move, you are not alone. The French animal health specialist has been on a bit of a rollercoaster recently, making investors sit up and reconsider its l...
Virbac : Declaration of the number of shares and voting rights 08/2025
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
